BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12717803)

  • 1. Analysis of the interaction between alpha-1-acid glycoprotein and tamoxifen and its metabolites.
    Paterson SC; Lim CK; Smith KD
    Biomed Chromatogr; 2003; 17(2-3):143-8. PubMed ID: 12717803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of certain anti-tuberculosis drugs is affected by binding to alpha-1-acid glycoprotein.
    Johnson DA; Smith KD
    Biomed Chromatogr; 2006; 20(6-7):551-60. PubMed ID: 16779786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of primaquine in human blood: drug-binding to alpha 1-glycoprotein.
    Kennedy E; Frischer H
    J Lab Clin Med; 1990 Dec; 116(6):871-8. PubMed ID: 2246561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of 4-hydroxy-N-desmethyltamoxifen and other tamoxifen metabolites in human biological fluids during tamoxifen treatment.
    Lien EA; Solheim E; Lea OA; Lundgren S; Kvinnsland S; Ueland PM
    Cancer Res; 1989 Apr; 49(8):2175-83. PubMed ID: 2702659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of alpha-1-acid glycoprotein binding on pharmacokinetics and pharmacodynamics.
    Huang Z; Ung T
    Curr Drug Metab; 2013 Feb; 14(2):226-38. PubMed ID: 23092311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased serum concentrations of tamoxifen and its metabolites induced by aminoglutethimide.
    Lien EA; Anker G; Lønning PE; Solheim E; Ueland PM
    Cancer Res; 1990 Sep; 50(18):5851-7. PubMed ID: 2393854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of tamoxifen metabolites in human Hep G2 cell line, human liver homogenate, and patients on long-term therapy for breast cancer.
    Poon GK; Walter B; Lønning PE; Horton MN; McCague R
    Drug Metab Dispos; 1995 Mar; 23(3):377-82. PubMed ID: 7628304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.
    Murphy LC; Peng B; Lewis A; Davie JR; Leygue E; Kemp A; Ung K; Vendetti M; Shiu R
    J Mol Endocrinol; 2005 Apr; 34(2):553-66. PubMed ID: 15821116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clindamycin-paclitaxel pharmacokinetic interaction in ovarian cancer patients.
    Fruscio R; Lissoni AA; Frapolli R; Corso S; Mangioni C; D'Incalci M; Zucchetti M
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):319-25. PubMed ID: 16362296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of alpha1-acid glycoprotein to membrane results in a unique structural change and ligand release.
    Nishi K; Maruyama T; Halsall HB; Handa T; Otagiri M
    Biochemistry; 2004 Aug; 43(32):10513-9. PubMed ID: 15301549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of acid alpha 1-glycoprotein with immunoglobulins.
    Wróblewski Z
    Acta Biochim Pol; 1981; 28(1):21-30. PubMed ID: 7282213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of alpha-1 acid glycoprotein as a lysophospholipid binding protein: a complementary role to albumin in the scavenging of lysophosphatidylcholine.
    Ojala PJ; Hermansson M; Tolvanen M; Polvinen K; Hirvonen T; Impola U; Jauhiainen M; Somerharju P; Parkkinen J
    Biochemistry; 2006 Nov; 45(47):14021-31. PubMed ID: 17115697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Respective role of mifepristone (RU486) binding to blood and tissue proteins in its quantitative distribution in the body].
    Grimaldi B; Barre J; Tillement JP
    C R Acad Sci III; 1992; 315(3):93-9. PubMed ID: 1422922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of age-related alteration of plasma alpha 1-acid glycoprotein concentration on erythromycin pharmacokinetics in pigs.
    Kinoshita T; Son DS; Shimoda M; Kokue E
    Am J Vet Res; 1995 Mar; 56(3):362-5. PubMed ID: 7771705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence.
    Mc Ilroy M; Fleming FJ; Buggy Y; Hill AD; Young LS
    Endocr Relat Cancer; 2006 Dec; 13(4):1135-45. PubMed ID: 17158759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approach for reliable evaluation of drug proteins interactions using surface plasmon resonance technology.
    Sandblad P; Arnell R; Samuelsson J; Fornstedt T
    Anal Chem; 2009 May; 81(9):3551-9. PubMed ID: 19338267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of alpha1-acid glycoprotein in inter-individual variation of disposition kinetics of ropivacaine following epidural infusion in off-pump coronary artery bypass grafting.
    Yokogawa K; Shimomura S; Ishizaki J; Shimada T; Fukuwa C; Kawada M; Tsubokawa T; Yamamoto K; Miyamoto K
    J Pharm Pharmacol; 2007 Jan; 59(1):67-73. PubMed ID: 17227622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
    Frankel LB; Lykkesfeldt AE; Hansen JB; Stenvang J
    Breast Cancer Res Treat; 2007 Aug; 104(2):165-79. PubMed ID: 17061041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of disulfide bonds and histidine 172 in a unique beta-sheet to alpha-helix transition of alpha 1-acid glycoprotein at the biomembrane interface.
    Nishi K; Komine Y; Fukunaga N; Maruyama T; Suenaga A; Otagiri M
    Proteins; 2006 May; 63(3):611-20. PubMed ID: 16470806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
    Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
    Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.